The study can’t supplant an RCT in this space, but does provide clear support for both short DAPT and P2Y12 inhibitors ...

Continuing the conversation, Juan Granada hears about Guido Ascione’s recent presentation on the global burden of ...

Johanne Silvain, Gilles Montalescot, and C. Michael Gibson discuss the effects of beta-blocker interruption in post-MI ...

Japanese registry data point to fewer deaths and heart failure hospitalizations, especially when MR is reduced to mild or ...

Effects are more modest in placebo-controlled versus nonrandomized studies, with experts calling for further research.

The advantage over balloon angioplasty in this higher-risk subset was consistent with the results seen in single-layer ISR.

The findings are encouraging but likely don’t apply to countries with ready access to thrombectomy, one expert says.

Despite the rising interest in procedures like TEER and LAAO, finances may sway decision-making, experts caution.

While increasing accessibility is “laudable,” it can come at a cost when patients leave the VA for procedures, Jay Giri says.

ATTAIN-1 is the second trial this year to show positive results with once-daily orforglipron, with best results seen at the ...

In-store opportunities for patients to check in with their health may offer touchpoints to those who don’t regularly seek ...

Access to rehabilitation is a “lifeline” for patients that needs to be protected and preserved to ensure their recovery.